TABLE 3.
Overall population | LIBRA score a | |||
---|---|---|---|---|
Low | Intermediate | High | ||
Overall population |
652/5170 1.5 (1.4–1.6) |
132/1383 1.1 (0.9–1.2) |
297/2503 1.4 (1.2–1.6) |
223/1284 2.3 (2.0–2.7) |
APOE ε4 carrier status | ||||
Non‐carrier | 479/4131 | 99/1107 | 215/2008 | 165/1016 |
1.4 (1.2–1.5) | 1.0 (0.8–1.2) | 1.2 (1.1–1.4) | 2.1 (1.8–2.5) | |
Carrier | 173/1039 | 33/276 | 82/495 | 58/268 |
2.1 (1.8–2.5) | 1.4 (1.0–1.9) | 2.1 (1.6–2.5) | 3.3 (2.5–4.3) | |
GRS b | ||||
Low | 187/1724 | 44/494 | 85/817 | 58/413 |
1.3 (1.1–1.5) | 1.0 (0.7–1.3) | 1.2 (1–1.5) | 1.9 (1.4–2.4) | |
Medium | 212/1723 | 41/443 | 96/865 | 75/415 |
1.5 (1.3–1.7) | 1.0 (0.7–1.4) | 1.4 (1.1–1.7) | 2.2 (1.7–2.7) | |
High | 253/1723 | 47/446 | 116/821 | 90/456 |
1.8 (1.6–2.0) | 1.2 (0.9–1.6) | 1.6 (1.3–1.9) | 3.0 (2.4–3.7) |
Abbreviations: APOE, apolipoprotein E; CI, confidence interval; GRS, genetic risk score.
Note: Data are number of incident cases/total and incidence rate per 100 person‐year (95% CI).
Low, intermediate, and high LIBRA risk score categories were defined as the first quartile, second and third quartiles, and fourth quartile of the score, respectively.
Low, medium, and high genetic risk score categories were defined as the first, second, and third tertiles of the score, respectively.